Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer

Abstract

Recurrent prostate cancer may develop the capacity to biosynthesize testicular androgens from adrenal androgens or cholesterol. This surprising finding suggests intracrine production of dihydrotestosterone and should be exploited for novel treatment of recurrent prostate cancer.